K081576 is an FDA 510(k) clearance for the BLAZER DX-20 DIAGNOSTIC CATHETER. This device is classified as a Catheter, Electrode Recording, Or Probe, Electrode Recording (Class II - Special Controls, product code DRF).
Submitted by Boston Scientific Corp (San Jose, US). The FDA issued a Cleared decision on February 3, 2009, 243 days after receiving the submission on June 5, 2008.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1220.
| 510(k) Number | K081576 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | June 05, 2008 |
| Decision Date | February 03, 2009 |
| Days to Decision | 243 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DRF — Catheter, Electrode Recording, Or Probe, Electrode Recording |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 870.1220 |